JPWO2021099531A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021099531A5
JPWO2021099531A5 JP2022529813A JP2022529813A JPWO2021099531A5 JP WO2021099531 A5 JPWO2021099531 A5 JP WO2021099531A5 JP 2022529813 A JP2022529813 A JP 2022529813A JP 2022529813 A JP2022529813 A JP 2022529813A JP WO2021099531 A5 JPWO2021099531 A5 JP WO2021099531A5
Authority
JP
Japan
Prior art keywords
orally disintegrating
months
disintegration
tablet according
zonisamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022529813A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023502738A5 (https=
JP7650274B2 (ja
JP2023502738A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/082809 external-priority patent/WO2021099531A1/en
Publication of JP2023502738A publication Critical patent/JP2023502738A/ja
Publication of JP2023502738A5 publication Critical patent/JP2023502738A5/ja
Publication of JPWO2021099531A5 publication Critical patent/JPWO2021099531A5/ja
Application granted granted Critical
Publication of JP7650274B2 publication Critical patent/JP7650274B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022529813A 2019-11-22 2020-11-20 ゾニサミド口腔分散性錠剤 Active JP7650274B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19383034 2019-11-22
EP19383034.6 2019-11-22
PCT/EP2020/082809 WO2021099531A1 (en) 2019-11-22 2020-11-20 Zonisamide orodispersible tablets

Publications (4)

Publication Number Publication Date
JP2023502738A JP2023502738A (ja) 2023-01-25
JP2023502738A5 JP2023502738A5 (https=) 2023-11-08
JPWO2021099531A5 true JPWO2021099531A5 (https=) 2023-11-08
JP7650274B2 JP7650274B2 (ja) 2025-03-24

Family

ID=68808236

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022529813A Active JP7650274B2 (ja) 2019-11-22 2020-11-20 ゾニサミド口腔分散性錠剤

Country Status (5)

Country Link
EP (1) EP4061328B1 (https=)
JP (1) JP7650274B2 (https=)
ES (1) ES2976470T3 (https=)
PT (1) PT4061328T (https=)
WO (1) WO2021099531A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024090218A (ja) * 2022-12-22 2024-07-04 ダイト株式会社 崩壊遅延を改善したゾニサミド含有口腔内速崩壊錠
AU2024227385A1 (en) * 2024-03-28 2025-10-16 Athena Pharmaceutiques Sas Lisdexamfetamine dimesylate orodispersible tablet and process for preparation thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4989733B2 (ja) 2008-02-13 2012-08-01 大日本住友製薬株式会社 口腔内崩壊錠
JP5680898B2 (ja) 2010-08-10 2015-03-04 京都薬品工業株式会社 苦味を抑制した速崩壊錠
JP6230539B2 (ja) 2012-09-20 2017-11-15 株式会社ダイセル 酸型カルボキシメチルセルロース及び結晶セルロースを含む崩壊性粒子組成物及び該組成物を含む口腔内崩壊錠剤
JP6271802B1 (ja) 2017-09-28 2018-01-31 武田テバファーマ株式会社 口腔内崩壊錠

Similar Documents

Publication Publication Date Title
JP6162196B2 (ja) 遅延性持続ドラッグデリバリー
JP6162197B2 (ja) 即時／遅延ドラッグデリバリー
JP2021512117A5 (https=)
JP2011500583A5 (https=)
JP2015091822A5 (https=)
CN102341099A (zh) R-巴氯芬前药的持续释放口服剂型
CN102170870A (zh) 恩他卡朋或其盐的缓释药物组合物
JPH05213741A (ja) デプレニル／ｌ−ドーパ／カルビドーパ含有の医薬組成物
TWI491395B (zh) 一種內含用以治療神經退化性疾病之立即釋出與長效釋出藥物的口服劑量配方
JP2019142834A (ja) プレガバリン並びに好適な賦形剤を含有する固形製剤
JP2018118966A5 (https=)
JP2019019113A (ja) メマンチン塩酸塩含有口腔内崩壊錠
EP3813822A2 (en) Solid oral pharmaceutical compositions comprising teriflunomide
JP6366794B2 (ja) 原薬の化学的安定性や服用感を向上した、口腔内崩壊錠
JP2017048174A (ja) 化学的に安定な原薬含有被覆粒子を含む口腔内崩壊錠剤
JPWO2021099531A5 (https=)
JP2019052147A (ja) 化学的な安定性が改善された、プレガバリン含有口腔内崩壊錠
WO2013109225A1 (en) Pharmaceutical tablet formulations comprising ceftibuten
WO2012080703A1 (en) Pharmaceutical composition comprising imatinib
KR20130023127A (ko) 프레가발린을 포함하는 서방성 제제
JP2018118909A (ja) プレガバリン含有医薬組成物
WO2013180675A1 (en) Tablet formulation comprising dapoxetine
JP2019182859A (ja) 口腔内崩壊錠
JP7423297B2 (ja) 口腔内崩壊錠およびその製造方法
EP3687539A1 (en) Stable pharmaceutical compositions of dalfampridine